Clinical trials
Neoplasms trials in Chile
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
63 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2005 | 1 |
| 2007 | 4 |
| 2008 | 5 |
| 2009 | 3 |
| 2010 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 11 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 8 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 28 |
| Recruiting | 16 |
| Active, not recruiting | 8 |
| Terminated | 5 |
| Unknown status | 4 |
| No longer available | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 9 |
| Novartis Pharmaceuticals | 4 |
| Sanofi | 4 |
| Amgen | 3 |
| Bayer | 3 |
| Bristol-Myers Squibb | 3 |
| Fundación para la Investigación del Hospital Clínico de Valencia | 3 |
| Pontificia Universidad Catolica de Chile | 3 |
| AbbVie | 2 |
| Astellas Pharma Global Development, Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 63 |
| Breast Neoplasms | 8 |
| Stomach Neoplasms | 7 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Carcinoma, Renal Cell | 4 |
| Esophageal Neoplasms | 4 |
| Neoplasm Metastasis | 4 |
| Pain | 4 |
| Adenocarcinoma | 3 |
| Carcinoma | 3 |
Trials
Showing 76 to 63 of 63. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.